A Phase II Trial of Intensive Chemotherapy [temozolomide, busulfan, thiotepa] and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma

Trial Profile

A Phase II Trial of Intensive Chemotherapy [temozolomide, busulfan, thiotepa] and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Feb 2018

At a glance

  • Drugs Temozolomide (Primary) ; Busulfan; Thiotepa
  • Indications Oligodendroglioma
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Feb 2018 Planned End Date changed from 1 Sep 2018 to 1 Sep 2019.
    • 23 Feb 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Sep 2019.
    • 08 Mar 2017 Planned End Date changed from 1 Sep 2017 to 1 Sep 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top